Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01051609 · ClinicalTrials.gov registry record
Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 27
- Enrollment target
NCT01051609 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 27 participants.
The verdict
NCT01051609 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to compare pre and post Aromatase Inhibitor (AI) treatment serological markers of inflammation and assess for correlation with AI-MS.
Interventions
- OTHER Blood Collection
- BEHAVIORAL Surveys
- OTHER History and Physical Exam
- OTHER Grip Strength Measurement
- PROCEDURE Ultrasound of Hand/Wrist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01051609
The ClinicalTrials.gov registry entry for NCT01051609 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood Collection is the first listed.
NCT01051609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01051609 about?
NCT01051609 is a clinical study titled "Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients". The purpose of this study is to compare pre and post Aromatase Inhibitor (AI) treatment serological markers of inflammation and assess for correlation with AI-MS.
What is the current status of trial NCT01051609?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01051609?
The interventions under investigation include: Blood Collection (OTHER), Surveys (BEHAVIORAL), History and Physical Exam (OTHER), Grip Strength Measurement (OTHER), Ultrasound of Hand/Wrist (PROCEDURE).
Who is sponsoring clinical trial NCT01051609?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.